April 19 The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Japan's Takeda Pharmaceutical is in negotiations with Shire after making a third takeover bid worth around $61 billion that was rejected by the London-listed rare diseases drugmaker. ** Brazil's state-run oil company Petroleo Brasileiro SA is considering selling 60 percent stakes in two regional blocks comprising four refineries, and keeping full ownership of nine other units,
* UNIT BOULE MEDICAL AB BUYS NEW TECHNOLOGIES FROM DREW SCIENTIFIC, INC.
BRIEF-Novartis AG CFO Says Q2 Core Operating Profit Growth To Be In Low To Mid Single Digits, Improvements To Come
* CFO SAYS Q2 CORE OPERATING PROFIT GROWTH TO BE IN LOW TO MID SINGLE DIGITS, FOLLOWED BY IMPROVEMENTS LATER IN YEAR
* NAMASTE RECEIVES CONDITIONAL APPROVAL TO LIST ON TSX VENTURE EXCHANGE Source text for Eikon: Further company coverage:
* SINOVAC ANNOUNCES PRELIMINARY RESULTS OF PHASE III TRIAL ON SIPV
No related earnings announcements are currently scheduled within the next 7 days.